Retraction: Modification of glycosylation mediates the invasive properties of murine hepatocarcinoma cell lines to lymph nodes (PLoS One (2013) 8:6 (e65218) DOI: 10.1371/journal.pone.0065218);Modification of Glycosylation Mediates the Invasive Properties of Murine Hepatocarcinoma Cell Lines to Lymph Nodes

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Zhang, Zhaohai ^a   Sun, Jie ^a,b   Hao, Lihong ^a   Liu, Chunqing ^a   Ma, Hongye ^a   Jia, Li ^a  

^a DALIAN MEDICAL UNIVERSITY   (China)

^b Department of Laboratory Medicine   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCAN; MEMBRANE PROTEIN; TUNICAMYCIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B3GNT8 GENE; B4GALT1 GENE; CARCINOMA CELL; CELL INVASION; CELL SURFACE; CONTROLLED STUDY; FLOW CYTOMETRY; FUT8 GENE; GENE; GENE EXPRESSION; GLYCOBIOLOGY; IN VITRO STUDY; IN VIVO STUDY; LECTIN BINDING; LIVER CELL CARCINOMA; LYMPH NODE METASTASIS; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; METASTASIS POTENTIAL; MGAT5 GENE; MOUSE; NONHUMAN; PROTEIN GLYCOSYLATION; ST6GAL1 GENE;

MURINAE;

EID: 84879263293     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0222417     Document Type: Erratum

References (44)

1. Dwek RA, (1995) Glycobiology: "towards understanding the function of sugars". Biochem Soc Trans 23: 1-25.
2. Taniguchi N, Ekuni A, Ko JH, Miyoshi E, Ikeda Y, et al. (2001) A glycomic approach to the identification and characterization of glycoprotein function in cells transfected with glycosyltransferase genes. Proteomics 1: 239-247.
3. Saxon E, Bertozzi CR, (2001) Annu. Chemical and biological strategies for engineering cell surface glycosylation. Rev Cell Dev Biol 17: 1-23.
4. Ohtsubo K, Marth JD, (2006) Glycosylation in cellular mechanisms of health and disease. Cell 126: 855-867.
5. Dennis JW, Granovsky M, Warren CE, (1999) Glycoprotein glycosylation and cancer progression. Biochim Biophys Acta 1473: 21-34.
6. Balog CI, Stavenhagen K, Fung WL, Koeleman CA, McDonnell LA, et al. (2012) N-glycosylation of colorectal cancer tissues: a liquid chromatography and mass spectrometry-based investigation. Mol Cell Proteomics 11: 571-585.
7. Dube DH Bertozzi CR, (2005) Glycans in cancer and inflammation-potential for therapeutics and diagnostics. Nat Rev Drug Discov 4: 477-488.
8. Mehta A, Norton P, Liang H, Comunale MA, Wang M, et al. (2012) Increased Levels of Tetra-antennary N-Linked Glycan but Not Core Fucosylation Are Associated with Hepatocellular Carcinoma Tissue. Cancer Epidemiol Biomarkers Prev 21: 925-933.
9. de Leoz ML, Young LJ, An HJ, Kronewitter SR, Kim J, et al. (2011) High-mannose glycans are elevated during breast cancer progression. Mol Cell Proteomics 10: M110.002717.
10. Guo HB, Zhang Y, Chen HL, (2001) Relationship between metastasis-associated phenotypes and N-glycan structure of surface glycoproteins in human hepatocarcinoma cells. J Cancer Res Clin Oncol 127: 231-236.
11. Guo R, Cheng L, Zhao Y, Zhang J, Liu C, et al. (2013) Glycogenes mediate the invasive properties and chemosensitivity of human hepatocarcinoma cells. Int J Biochem Cell Bio 45: 347-358.
12. Sakuma K, Fujimoto I, Hitoshi S, Tanaka F, Ikeda T, et al. (2006) An N-glycan structure correlates with pulmonary metastatic ability of cancer cells. Biochem Biophys Res Commun 340: 829-835.
13. Granovsky M, Fata J, Pawling J, Muller WJ, Khokha R, et al. (2000) Suppression of tumor growth and metastsis in Mgat5-deficient mice. Nat Med 6: 306-312.
14. Hou L, Li Y, Jia YH, Wang B, Xin Y, et al. (2001) Molecular mechanism about lymphogenous metastasis of hepatocarcinoma cells in mice. World J Gastroenterol 7: 532-536.
15. Li HF, Ling MY, Xie Y, Xie H, (1998) Establishment of a lymph node metastatic model of mouse hepatocellular carcinoma Hca-F cells in C3H/Hej mice. Oncol Res 10: 569-573.
16. Jia L, Wang S, Zhou H, Hu Y, Zhang J, (2006) Caveolin-1 upregulates CD147 glycosylation and the invasive capability of murine hepatocarcinoma cell lines. Int J Biochem Cell Biol 38: 1584-1593.
17. Costello CE, Contado-Miller JM, Cipollo JF, (2007) A glycomics platform for the analysis of permethylated oligosaccharide alditols. J Am Soc Mass Spectrom 18: 1799-1812.
18. Viseux N, Costello CE, Domon B, (1999) Post-source decay mass spectrometry: optimized calibration procedure and structural characterization of permethylated oligosaccharides. J Mass Spectrom 34: 364-376.
19. Tang W, Chang SB, Hemler ME, (2004) Links between CD147 Function, Glycosylation, and Caveolin-1. Molecular Biology of the Cell 15: 4043-4050.
20. Dell A, Morris HR, (2001) Glycoprotein Structure Determination by Mass Spectrometry. Science 291: 2351-2356.
21. Harvey DJ, (2005) Proteomic analysis of glycosylation: structural determination of N-and O-linked glycans by mass spectrometry. Expert Rev Proteomics 2: 87-101.
22. Zaia J, (2004) Mass spectrometry of oligosaccharides. Mass Spectro Rev 3: 161-227.
23. Zhang MH, Xu XH, Wang Y, Ling QX, Bi YT, et al. (2013) A Prognostic Biomarker for Gastric Cancer With Lymph Node Metastases. Anat Rec (Hoboken) Feb 4 doi: 10.1002/ar.22642.
24. Goldman R, Ressom HW, Varghese RS, Goldman L, Bascug G, et al. (2009) Detection of Hepatocellular Carcinoma Using Glycomic Analysis. Clin. Cancer Res 15: 1808-1813.
25. Dwek RA, (1996) Glycobiology: toward understanding the function of sugars. Chem Rev 96: 683-720.
26. Varki A, (1993) Biological roles of oligosaccharides: all of the theories are correct. Glycobiology 3: 97-130.
27. Harduin-Lepers A. Vallejo-Ruiz V, Krzewinski-Recchi MA, Samyn-Petit B, Julien S, et al. (2001) The human sialyltransferase family. Biochimie 83: 727-737.
28. Hirabayashi J, (2004) Lectin-based structural glycomics: glycoproteomics and glycan profiling. Glycoconj J 21: 35-40.
29. Venable A, Mitalipova M, Lyons I, Jones K, Shin S, et al. (2005) Lectin binding profiles of SSEA-4 enriched, pluripotent human embryonic stem cell surfaces. BMC Dev Biol 21: 5-15.
30. Ruhaak LR, Miyamoto S, Lebrilla CB (2013) Developments in the identification of glycan biomarkers for the detection of cancer. Mol Cell Proteomics Jan 30. [Epub ahead of print].
31. Kim EH, Misek DE, (2011) Glycoproteomics-based identification of cancer biomarkers. Int J Proteomics 2011: 601937.
32. Calle Y, Palomares T, Castro B, del Olmo M, Bilbao P, et al. (2000) Tunicamycin treatment reduces intracellular glutathione levels: effect on the metastatic potential of the rhabdomyosarcoma cell line S4MH. Chemotherapy 46: 408-428.
33. Jia L, Zhou H, Wang S, Cao J, Wei W, et al. (2006) Deglycosylation of CD147 down-regulates Matrix Metalloproteinase-11 expression and the adhesive capability of murine hepatocarcinoma cell HcaF in vitro. IUBMB Life 58: 209-216.
34. Muramatsu T, Miyauchi T, (2003) Basigin (CD147): a multifunctional transmembrane protein involved in reproduction, neural function, inflammation and tumor invasion. Histol and Histopathol 18: 981-987.
35. Gessner P, Riedl S, Quentmaier A, Kemmner W, (1993) Enhanced activity of CMP-NeuAc:Galh 1-4GlcNAc:a 2,6-sialyltransferase in metastasizing human colorectal tumor tissue and serum of tumor patients. Cancer Lett 75: 143-149.
36. Recchi MA, Harduin-Lepers A, Boilly-Marer Y, Verbert A, Delannoy P, (1998) Multiplex RT-PCR method for the analysis of the expression of human sialyltransferases: application to breast cancer cells. 5: 19-27.
37. Li J, Wang Y, Xie Y, Xu Z, Yang J, et al. (2012) Altered mRNA expressions of sialyltransferases in human gastric cancer tissues. Med Oncol 29: 84-90.
38. Wang PH, Lee WL, Juang CM, Yang YH, Lo WH, et al. (2005) Altered mRNA expressions of sialyltransferases in ovarian cancers. Gynecologic Oncology 99: 631-639.
39. Skacel PO, Edwards AJ, Harrison CT, Watkins WM, (1991) Enzymic control of the expression of the X determinant (CD15) in human myeloid cells during maturation: the regulatory role of 6′-sialyltransferase. Blood 78: 1452-1460.
40. Kaneko Y, Yamamoto H, Kersey DS, Colley KJ, Leestma JE, et al. (1996) The expression of Galh1,4GlcNAc a2,6 sialyltransferase and a2,6-linked sialoglycoconjugates in human brain tumors. Acta Neuropathol (Berl) 91: 284-292.
41. Lin S, Kemmner W, Grigull S, Schlag PM, (2002) Cell surface alpha 2,6 sialylation affects adhesion of breast carcinoma cells. Exp Cell Res. 276: 101-110.
42. Christie DR, Shaikh FM, Lucas JA, Bellis SL, (2008) ST6Gal-I expression in ovarian cancer cells promotes an invasive phenotype by altering integrin glycosylation and function. J Ovarian Res 1: 3.
43. Zhu Y, Srivatana U, Ullah A, Gagneja H, Berenson CS, et al. (2001) Suppression of a sialyltransferase by antisense DNA reduces invasiveness of human colon cancer cells in vitro. Biochim Biophys Acta 1536: 148-160.
44. Yu S, Zhang L, Li N, Fan J, Liu L, et al. (2012) Caveolin-1 up-regulates ST6Gal-I to promote the adhesive capability of mouse hepatocarcinoma cells to fibronectin via FAK-mediated adhesion signaling. Biochem Biophys Res Commun 427: 506-512.